These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27168788)

  • 21. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection.
    Nakamura Y; Aikata H; Fukuhara T; Honda F; Morio K; Morio R; Hatooka M; Kobayashi T; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ochi H; Kobayashi T; Ohdan H; Shiroma N; Arihiro K; Chayama K
    Hepatol Res; 2017 Jul; 47(8):767-772. PubMed ID: 27591427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.
    Li B; Zhang L; Zhang Z; Yan G; Zhu L; Lu W; Yu H
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):218-223. PubMed ID: 30277926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum S100 calcium binding protein A4 improves the diagnostic accuracy of transient elastography for assessing liver fibrosis in hepatitis B.
    Yan LB; Zhang QB; Zhu X; He M; Tang H
    Clin Res Hepatol Gastroenterol; 2018 Feb; 42(1):64-71. PubMed ID: 28688902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.
    Cardoso AC; Beaugrand M; de Ledinghen V; Douvin C; Poupon R; Trinchet JC; Ziol M; Bedossa P; Marcellin P
    Ann Hepatol; 2015; 14(6):826-36. PubMed ID: 26436354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases.
    Oliveri F; Coco B; Ciccorossi P; Colombatto P; Romagnoli V; Cherubini B; Bonino F; Brunetto MR
    World J Gastroenterol; 2008 Oct; 14(40):6154-62. PubMed ID: 18985805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan FK; Sung JJ; Chan HL
    J Gastroenterol Hepatol; 2009 Jun; 24(6):1002-7. PubMed ID: 19457152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients.
    Guo L; Zheng L; Hu L; Zhou H; Yu L; Liang W
    Med Sci Monit; 2017 Oct; 23():5106-5112. PubMed ID: 29073121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
    Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
    J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
    Behairy Bel-S; Sira MM; Zalata KR; Salama el-SE; Abd-Allah MA
    World J Gastroenterol; 2016 Apr; 22(16):4238-49. PubMed ID: 27122674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of transient elastography in Japanese patients with non-alcoholic fatty liver disease.
    Seki K; Shima T; Oya H; Mitsumoto Y; Mizuno M; Okanoue T
    Hepatol Res; 2017 Aug; 47(9):882-889. PubMed ID: 27753194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients.
    Kim BK; Han KH; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Kim DY
    Liver Int; 2010 Aug; 30(7):1073-81. PubMed ID: 20492510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases.
    Wong GL; Wong VW; Choi PC; Chan AW; Chum RH; Chan HK; Lau KK; Chim AM; Yiu KK; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1027-35. PubMed ID: 18456573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
    Wu Z; Dong X; Wang G; Zhao H;
    J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy.
    Yan LB; Zhu X; Bai L; Liang LB; Chen EQ; Du LY; Wang LC; Chen LY; Tang H
    Hepatol Res; 2013 Feb; 43(2):185-91. PubMed ID: 22978384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.
    Xiao HM; Shi MJ; Jiang JM; Cai GS; Xie YB; Tian GJ; Xue JD; Mao DW; Li Q; Yang HZ; Guo H; Lei CL; Lu W; Chen L; Liu HB; Wang J; Gao YQ; Chen JZ; Wu SD; Chen HJ; Zhao PT; Zhang CZ; Ou-Yang WW; Wen ZH; Chi XL
    J Ethnopharmacol; 2022 Jul; 293():115210. PubMed ID: 35398501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
    Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V
    Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.
    Marcellin P; Ziol M; Bedossa P; Douvin C; Poupon R; de Lédinghen V; Beaugrand M
    Liver Int; 2009 Feb; 29(2):242-7. PubMed ID: 18637064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study.
    Afdhal NH; Bacon BR; Patel K; Lawitz EJ; Gordon SC; Nelson DR; Challies TL; Nasser I; Garg J; Wei LJ; McHutchison JG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):772-9.e1-3. PubMed ID: 25528010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.
    Chang PE; Hartono JL; Ngai YL; Dan YY; Lim KB; Chow WC
    Singapore Med J; 2019 Oct; 60(10):532-537. PubMed ID: 30556091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.